At this time, posts about Gwangdong Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have tentatively been recorded as net buyers of 1,188 shares of Gwangdong Pharmaceutical, while institutions have been net sellers of 2,000 shares. Gwangdong Pharmaceutical is known as a pharmaceutical company specializing in herbal products and health beverages.
As of 11:31 AM on the 15th, Gwangdong Pharmaceutical's stock price is 10,950 KRW, down 5.19% from the previous day, with a trading volume of 1,901,445 shares, which is 22.18% of the 5-day average trading volume. On October 8th, Gwangdong Pharmaceutical became a market issue with the news of 'Povidone' suppressing COVID-19, rising 7%.
In addition to Gwangdong Pharmaceutical, posts by investors are also rapidly increasing for Hyundai Pharm (004310), Some Age (208640), and KMH (122450).

※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
